GSK, the British pharmaceutical giant, has significantly raised its long-term sales outlook for the period between 2026 and 2031. The company anticipates that the launch of new drugs and vaccines will propel its annual sales to reach £38 billion by the beginning of the next decade. One of the key factors contributing to this positive projection is the hugely successful release … [Read more...] about GSK Raises Long-Term Sales Outlook
Footer
